#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Sandra Spalek"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
#DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
#DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
#DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
#DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
#DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
#DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns"
#DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
#DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mgi-names.belns"
#DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
#DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
#DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
#DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
#DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
#DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
#DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
#DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
#DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
#DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
#DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
#DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
#DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
#DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
#DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
#DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
#DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
#DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "25652642"}

SET Evidence = "The constitutive form is transcriptionally active as evidenced by the nuclear
localization of the p50 and p65 subunits in the neurons of the cortex and hippocampus"
SET MeSHAnatomy = {"Cerebral Cortex","Hippocampus"}
complex(p(HGNC:NFKB1),p(HGNC:RELA),a(GO:"NF-kappaB complex")) -> act(complex(GO:"NF-kappaB p50/p65 complex"))
UNSET MeSHAnatomy

SET Evidence = "In conditional neuronal NF-κB-deficient mice, loss of NF-κB signaling impaired synaptic
transmission, spatial memory formation, and plasticity"
act(complex(GO:"NF-kappaB complex")) -> bp(MESH:"Synaptic Transmission")
act(complex(GO:"NF-kappaB complex")) -> path(MESH:"Spatial Memory")
act(complex(GO:"NF-kappaB complex")) -> bp(GO:"positive regulation of synaptic plasticity")

SET Evidence = "A number of physiological stimuli including membrane depolarization or glutamergic signal
transduction lead to rapid activation of the inducible NF-κB localized in the synapses,
cytoplasm and dendrites of the neurons"
SET MeSHAnatomy = {"Synapses","Cytoplasm","Dendrites","Neurons"}
bp(GO:"membrane depolarization") -> act(complex(GO:"NF-kappaB complex"))
bp(GO:"synaptic transmission, glutamatergic") -> act(complex(GO:"NF-kappaB complex"))
UNSET MeSHAnatomy

SET Evidence = "Complete abrogation of the DNA binding ability of NFκB factors induces apoptosis of the neuronal cells"
SET MeSHAnatomy = "Neurons"
act(complex(GO:"NF-kappaB complex")) -| bp(GO:"apoptotic process")
UNSET MeSHAnatomy

SET Evidence = " Cell death is preceded by reduction in the
NF-κB regulated transcription of anti-apoptotic genes suggesting that a minimal threshold of
NF-κB activity is needed for neuronal survival"
act(complex(GO:"NF-kappaB complex")) -| bp(GO:"neuron death")

SET Evidence = "Several kinase pathways
including the calcium-calmodium dependent kinase-II (CaMK), the protein kinases-C (PKC)
and the ras/phosphatidylinositol 3-kinase (PI3K) pathways have been implicated in
activating neuronal NF-κB signaling"
SET MeSHAnatomy = "Neurons"
bp(GO:"calmodulin dependent kinase signaling pathway") -> act(complex(GO:"NF-kappaB complex"))
act(p(FPLX:PKC)) -> act(complex(GO:"NF-kappaB complex"))
bp(GO:"phosphatidylinositol 3-kinase signaling") -> act(complex(GO:"NF-kappaB complex"))
UNSET MeSHAnatomy

SET Evidence = "Unlike neurons, NF-κB is present in the cytoplasm as an
inactive complex with the IκB proteins in glial cells under physiological conditions"
SET MeSHAnatomy = {"Cytoplasm","Neuroglia"}
a(MESH:"I-kappa B Proteins") -| act(complex(GO:"NF-kappaB complex"))
UNSET MeSHAnatomy

SET Evidence = "Various endogenous and exogenous stimuli
activate NF-κB enhancing transactivation of inflammatory molecules and production of free
radicals in glial cells"
SET MeSHAnatomy = "Neuroglia"
act(complex(GO:"NF-kappaB complex")) -> bp(GO:"inflammatory response")
act(complex(GO:"NF-kappaB complex")) -> a(MESH:"Free Radicals")
UNSET MeSHAnatomy

SET Evidence = "Glutamate induced stimulation of cerebellar granule cells via the N-methyl-D-aspartate (NMDA)
receptor activate p65:p50 dimers and enhance transactivation of pro-apoptotic factors"
a(CHEBI:"glutamate(1-)") -> act(a(MESH:"Receptors, N-Methyl-D-Aspartate"))
a(CHEBI:"glutamate(1-)") -> act(complex(p(HGNC:NFKB1),p(HGNC:RELA)))
act(complex(p(HGNC:NFKB1),p(HGNC:RELA))) -> bp(GO:"apoptotic process")

SET MeSHDisease = "Alzheimer Disease"

SET Evidence = "A consequence of intracellular and parenchymal accumulation of NPs and NFTs is activation
of NF-κB in the neural and glial cells with subsequent protective or detrimental effects"
# NPs: neuritic plaques
# NFTS: neurofibrillary tangles
SET MeSHAnatomy = {"Neurons","Neuroglia"}
a(GO:"neurofibrillary tangle") pos act(complex(GO:"NF-kappaB complex"))
path(MESH:"Plaque, Amyloid") pos act(complex(GO:"NF-kappaB complex"))
UNSET MeSHAnatomy

SET Evidence = " In neuronal cells Aβ1-42
peptide has been shown to regulate APP and BACE1 proteins in NF-κB dependent manner"
SET MeSHAnatomy = "Neurons"
a(CHEBI:"amyloid-beta polypeptide 42") reg p(HGNC:APP)
a(CHEBI:"amyloid-beta polypeptide 42") reg p(HGNC:BACE1)
a(CHEBI:"amyloid-beta polypeptide 42") -> act(complex(GO:"NF-kappaB complex"))
act(complex(GO:"NF-kappaB complex")) reg p(HGNC:APP)
act(complex(GO:"NF-kappaB complex")) reg p(HGNC:BACE1)
UNSET MeSHAnatomy

UNSET MeSHDisease

SET Evidence = "Under physiological conditions activation of NF-κB by endogenous Aβ reduces βAPP,
BACE1 and the γ-secretase activity, thereby lowering Aβ processing and facilitating Aβ
homeostasis"
a(CHEBI:"amyloid-beta") -> act(complex(GO:"NF-kappaB complex"))
act(complex(GO:"NF-kappaB complex")) -| p(HGNC:BACE1)
act(complex(GO:"NF-kappaB complex")) -| p(CONSO:"sAPP-beta")
act(complex(GO:"NF-kappaB complex")) -| bp(CONSO:"APP processing")
act(complex(GO:"NF-kappaB complex")) reg a(CHEBI:"amyloid-beta")

SET MeSHDisease = "Alzheimer Disease"

SET Evidence = " However in AD, exposure to high Aβ concentrations upregulates NF-κB
activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor
exacerbated Aβ production "
a(CHEBI:"amyloid-beta") pos act(complex(GO:"NF-kappaB complex"))
act(complex(GO:"NF-kappaB complex")) pos p(CONSO:"sAPP-beta")
act(complex(GO:"NF-kappaB complex")) pos bp(CONSO:"APP processing")

SET Evidence = "Aβ has been shown to upregulate APOE in astroglial cells.
This upregulation was inhibited by decoy-κB nucleotides supporting a critical role for NFκB in APOE function"
SET MeSHAnatomy = "Astrocytes"
a(CHEBI:"amyloid-beta") -> act(p(HGNC:APOE))
complex(GO:"NF-kappaB complex") -- act(p(HGNC:APOE))
UNSET MeSHAnatomy

SET Evidence = " Stimulation with the Aβ25-35 fragments induces
secretion of cytokines such as TNF-α and of neurotrophic factors such as nerve growth
factor (NGF) and brain derived nerve factor (BDNF) in NF-κB-dependent manner"
composite(complex(GO:"NF-kappaB complex"),a(MESH:"amyloid beta-protein (25-35)")) -> sec(p(HGNC:TNF))
composite(complex(GO:"NF-kappaB complex"),a(MESH:"amyloid beta-protein (25-35)")) -> sec(p(HGNC:NGF))
composite(complex(GO:"NF-kappaB complex"),a(MESH:"amyloid beta-protein (25-35)")) -> sec(p(HGNC:BDNF))

SET Evidence = "Stimulation of neuronal cells by TNF-α has been shown to upregulate transactivation of
anti-apoptotic gene products and neurotrophins such as Bcl-2 and NGF respectively"
SET MeSHAnatomy = "Neurons"
p(HGNC:TNF) -> p(HGNC:NGF)
p(HGNC:TNF) -> p(HGNC:BCL2)
UNSET MeSHAnatomy

SET Evidence = "Decoy κB nucleotides mediate cell death by blocking neurotrophins and anti-apoptotic factors
supporting an essential role for NF-κB in the neuroprotective process "
complex(GO:"NF-kappaB complex") -> bp(MESH:Neuroprotection)

SET Evidence = " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of
manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit
membrane depolarization, thereby preventing apoptosis induced by oxidative stress"
SET MeSHAnatomy = "Neurons"
a(MESH:"amyloid beta-protein (25-35)") -> act(complex(GO:"NF-kappaB complex"))
act(complex(GO:"NF-kappaB complex")) -> act(p(HGNC:SOD2))
act(complex(GO:"NF-kappaB complex")) -| a(CHEBI:peroxynitrite)
act(complex(GO:"NF-kappaB complex")) -| bp(GO:"membrane depolarization")
act(complex(GO:"NF-kappaB complex")) -| bp(GO:"apoptotic process")
bp(MESH:"Oxidative Stress") -> bp(GO:"apoptotic process")
UNSET MeSHAnatomy

SET Evidence = " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or
neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel
containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)"
SET MeSHAnatomy = "Neurons"
p(HGNC:GRM5) -> complex(p(HGNC:REL),a(GO:"NF-kappaB complex"))
p(HGNC:GRM5) -> act(p(HGNC:SOD2))
p(HGNC:GRM5) -> act(p(HGNC:BCL2L1))
complex(p(HGNC:REL),a(GO:"NF-kappaB complex")) -| act(a(CHEBI:"amyloid-beta"))
act(p(HGNC:SOD2)) -| act(a(CHEBI:"amyloid-beta"))
act(p(HGNC:BCL2L1)) -| act(a(CHEBI:"amyloid-beta"))
UNSET MeSHAnatomy

SET Evidence = "These NF-κB mediated neuroprotective effects have been largely
observed in early stages of neuronal regeneration in AD"
complex(GO:"NF-kappaB complex") reg bp(MESH:Neuroprotection)

SET Evidence = "Exposure of primary neuronal cells or post-mitotic neurons to Aβ1-42 peptide has been
shown to strongly activate the p50:p65 dimers and mediate neuronal cell death (Fig 1)"
SET MeSHAnatomy = "Neurons"
a(CHEBI:"amyloid-beta polypeptide 42") -> complex(p(HGNC:NFKB1),p(HGNC:RELA))
a(CHEBI:"amyloid-beta polypeptide 42") reg bp(GO:"cell death")
UNSET MeSHAnatomy

SET Evidence = ". Consistent with the cellular studies, increased immunostaining for NF-κB-p65 has been
observed in neurons and their processes in the hippocampal formation and entorhinal cortex in AD "
SET MeSHAnatomy = "Neurons"
path(MESH:"Alzheimer Disease") pos complex(a(GO:"NF-kappaB complex"),p(HGNC:RELA))
UNSET MeSHAnatomy

SET Evidence = "Comparison of the cellular distribution of NF-κB in the nucleus basalis of
Meynert of AD and control patients showed that the proportion of large cholinergic neurons
with elevated nuclear p65 was significantly increased in AD, suggesting an association
between NF–κB functions and the process of cholinergic degeneration"
path(MESH:"Alzheimer Disease") pos p(HGNC:RELA)
act(complex(GO:"NF-kappaB complex")) -| a(MESH:"Cholinergic Neurons")

SET Evidence = " Mechanistically, the Aβ induced neuronal apoptosis has been attributed to the increase in the ratio of proapoptotic gene (BAX)
transcription to that of the anti-apoptotic gene Bcl-Xl, and/or to the reduction in constitutively activated NF-κB with consequent
increase in the cytoplasmic IκB proteins"
a(CHEBI:"amyloid-beta") -> bp(GO:"neuron death")
a(CHEBI:"amyloid-beta") -> p(HGNC:BAX)
a(CHEBI:"amyloid-beta") -| p(HGNC:BCL2L1)
a(CHEBI:"amyloid-beta") -| act(complex(GO:"NF-kappaB complex"))
a(CHEBI:"amyloid-beta") -> a(MESH:"I-kappa B Proteins")

SET Evidence = "These observations substantiate a direct role of neuronal NF–κB activation in
the pathogenesis of AD"
SET MeSHAnatomy = "Neurons"
act(complex(GO:"NF-kappaB complex")) pos path(MESH:"Alzheimer Disease")
UNSET MeSHAnatomy

SET Evidence = " Excessive accumulation of Aβ1-42
stimulates microglial cells by signaling via receptor associated advanced glycation end
products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ),
phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of
inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen
species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)"
a(CHEBI:"amyloid-beta polypeptide 42") pos act(a(MESH:Microglia))
a(CHEBI:"amyloid-beta polypeptide 42") -> bp(GO:"positive regulation of advanced glycation end-product receptor activity")
bp(GO:"positive regulation of advanced glycation end-product receptor activity") -> act(a(MESH:Microglia))
a(CHEBI:"amyloid-beta polypeptide 42") -> bp(GO:"peroxisome proliferator activated receptor signaling pathway")
bp(GO:"peroxisome proliferator activated receptor signaling pathway") -> act(a(MESH:Microglia))
a(CHEBI:"amyloid-beta polypeptide 42") -> p(MESH:"I-kappa B Proteins",pmod(Ph))
p(MESH:"I-kappa B Proteins",pmod(Ph)) -> act(a(MESH:Microglia))
a(CHEBI:"amyloid-beta polypeptide 42") -> act(complex(GO:"NF-kappaB complex"))
act(complex(GO:"NF-kappaB complex")) -> act(a(MESH:Microglia))
act(complex(GO:"NF-kappaB complex")) -> act(a(MESH:Cytokines))
act(complex(GO:"NF-kappaB complex")) -> act(a(CHEBI:"glutamate(1-)"))
act(complex(GO:"NF-kappaB complex")) -> act(a(CHEBI:"reactive oxygen species"))
act(complex(GO:"NF-kappaB complex")) -> act(p(HGNC:NOS2))

SET Evidence = " Increased presence of
activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly
observed around the Aβ plaques in postmortem AD tissue"
path(MESH:"Plaque, Amyloid") -- complex(GO:"NF-kappaB complex")
path(MESH:"Alzheimer Disease") pos complex(GO:"NF-kappaB complex")
path(MESH:"Plaque, Amyloid") -- a(MESH:"HLA-DR Antigens")
path(MESH:"Alzheimer Disease") pos a(MESH:"HLA-DR Antigens")

SET Evidence = "Increased presence of NF-κB
mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues,
serum and CSF of AD patients"
complex(GO:"NF-kappaB complex") -> p(HGNC:IL1B)
complex(GO:"NF-kappaB complex") -> p(HGNC:IL6)
complex(GO:"NF-kappaB complex") -> p(HGNC:TNF)
path(MESH:"Alzheimer Disease") pos complex(GO:"NF-kappaB complex")
path(MESH:"Alzheimer Disease") pos p(HGNC:IL1B)
path(MESH:"Alzheimer Disease") pos p(HGNC:IL6)
path(MESH:"Alzheimer Disease") pos p(HGNC:TNF)

SET Evidence = "This is supported by the observation
that in mixed neuronal-glial cell cultures, Aβ induces increasing degree of neurotoxicity in
an NF-κB dependent manner in the presence of higher proportion of glial cells"
SET MeSHAnatomy = {"Neurons","Neuroglia"}
a(CHEBI:"amyloid-beta") -> path(CONSO:neurotoxicity)
a(CHEBI:"amyloid-beta") -> act(complex(GO:"NF-kappaB complex"))
act(complex(GO:"NF-kappaB complex")) -> path(CONSO:neurotoxicity)
UNSET MeSHAnatomy

SET Evidence = "Furthermore NF-κB specific inhibitor prevents iNOS and ROS upregulation in Aβ
stimulated cultures of astrocytes or mixed cortical cells"
act(complex(GO:"NF-kappaB complex")) -> act(a(CHEBI:"reactive oxygen species"))
act(complex(GO:"NF-kappaB complex")) -> act(p(HGNC:NOS2))

SET Evidence = "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a,
miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues"
SET MeSHAnatomy = {"Brain","Neuroglia"}
path(MESH:"Alzheimer Disease") pos m(HGNC:"MIR9-1")
complex(GO:"NF-kappaB complex") reg m(HGNC:"MIR9-1")
path(MESH:"Alzheimer Disease") pos m(HGNC:MIR34A)
complex(GO:"NF-kappaB complex") reg m(HGNC:MIR34A)
path(MESH:"Alzheimer Disease") pos m(HGNC:MIR125B1)
complex(GO:"NF-kappaB complex") reg m(HGNC:MIR125B1)
path(MESH:"Alzheimer Disease") pos m(HGNC:MIR146A)
complex(GO:"NF-kappaB complex") reg m(HGNC:MIR146A)
path(MESH:"Alzheimer Disease") pos m(HGNC:MIR155)
complex(GO:"NF-kappaB complex") reg m(HGNC:MIR155)
path(MESH:"Alzheimer Disease") pos m(HGNC:MIR339)
complex(GO:"NF-kappaB complex") reg m(HGNC:MIR339)
UNSET MeSHAnatomy

SET Evidence = "In AD brains, miRNA-125b is observed
as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein
and vimentin and negative correlation with reduced cyclin dependent kinase 2A"
SET MeSHAnatomy = "Brain"
m(HGNC:MIR125B1) pos p(HGNC:GFAP)
m(HGNC:MIR125B1) pos p(HGNC:VIM)
m(HGNC:MIR125B1) pos p(HGNC:CDKN2A)
UNSET MeSHAnatomy

UNSET MeSHDisease
